FoRx Therapeutics Funding: $61M Raised, Series A (2025)
FoRx Therapeutics is based in Basel, Switzerland. It has raised $61M in total funding. Latest round: Series A.
FoRx Therapeutics funding overview
FoRx Therapeutics is based in Basel, Switzerland. FoRx Therapeutics has raised $61M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for FoRx Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include EQT Life Sciences, Pfizer Ventures, Novartis Venture Fund, M Ventures, Vincent Brichard, Omega Funds and 2 others. 8 distinct backers are named across the disclosed rounds.
FoRx Therapeutics at a glance
Total raised
$61M
Latest round
Series A
Latest round date
December 2025
Headquarters
Basel, Switzerland
Notable investors
EQT Life Sciences, Pfizer Ventures, Novartis Venture Fund, M Ventures, Vincent Brichard, Omega Funds, Forbion, Pontifax Venture Capital
Frequently asked about FoRx Therapeutics funding
How much has FoRx Therapeutics raised?
FoRx Therapeutics has raised $61M in total disclosed funding across the rounds on record.
Who has invested in FoRx Therapeutics?
EQT Life Sciences, Pfizer Ventures, Novartis Venture Fund, M Ventures, Vincent Brichard, Omega Funds are named among the investors backing FoRx Therapeutics.
What was the latest FoRx Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2025.
Where is FoRx Therapeutics based?
FoRx Therapeutics is based in Basel, Switzerland.
When did FoRx Therapeutics last raise?
The last disclosed FoRx Therapeutics round closed in December 2025 at Series A.
We update the FoRx Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Basel and their backers are listed below.
